Interleukin Antagonists
- Name
- Interleukin Antagonists
- Accession Number
- DBCAT003773
- Description
Not Available
- Drugs
Drug Drug Description Reslizumab An IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults. Benralizumab A monoclonal antibody used to treat eosinophilic asthma. - Drugs & Drug Targets
Drug Target Type Reslizumab Interleukin-5 target Benralizumab Interleukin-5 receptor subunit alpha target Benralizumab Low affinity immunoglobulin gamma Fc region receptor III-A target